{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"A Health Podyssey","title":"BEST OF: What Most Favored Nation Drug Pricing Would Mean for the US","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/364cdcdb\"></iframe>","width":"100%","height":180,"duration":1435,"description":"A Health Podyssey is on vacation in July. We will return with new episodes in August 2026.\nThis episode originally aired on April 14, 2026.\nHealth Affairs' Rob Lott interviews James Robinson of the University of California Berkeley about his recent paper exploring most favored nation drug pricing, weighing its feasibility, likely effects on drug launch prices, and implications for global pharmaceutical innovation and investment. \n\nOrder the April 2026 issue of Health Affairs.","thumbnail_url":"https://img.transistorcdn.com/RneDq6FP97HYBXbb6ygZjKJa8RJU_wIDSHFVqnbfKe8/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzE0ODU4LzE2MDE0/MDI1NzEtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}